Millennium Management
ROIV icon

Millennium Management’s Roivant Sciences ROIV Stock Holding History

Millennium Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,600
Closed -$130K – 6566
2023
Q4 		$130K Buy
+11,600
New +$113K ﹤0.01% 5275

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management's ROIV Position: Q1 2026 in Review

Millennium Management reduced its Roivant Sciences (ROIV) stake by 33% in Q1 2026, selling an estimated $10.1M and leaving 803,801 shares worth $22.3M. The position accounts for 0.01% of the portfolio, ranked #1455.

Millennium Management first reported a position in ROIV in Q1 2022 and has held it in 14 quarters since. The position peaked at $39.2M in Q3 2025. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Millennium Management held 803,801 shares of Roivant Sciences worth $22.3M as of Q1 2026.
  • Millennium Management sold 393,791 Roivant Sciences shares in Q1 2026, an estimated $10.1M.
  • Roivant Sciences made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1455 holding.
  • Millennium Management first reported a position in Roivant Sciences in Q1 2022 and has held it in 14 quarters since.
  • Millennium Management's Roivant Sciences position peaked at $39.2M in Q3 2025.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.